1-8 of 8
B Sandmaier
Close
Sort by
Journal Articles

A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo.

B. Bruno, MD, M. Rotta, MD, F. Patriarca, MD, D. Mattei, MD, B. Allione, MD, F. Carnevale-Schianca, MD, A. Rambaldi, MD, M. Casini, MD, V. Montefusco, MD, M. Parma, MD, P. Bavaro, MD, F. Onida, MD, A. Busca, MD, L. Castagna, MD, M.P. Iori, MD, D. Maloney, MD, B. Sandmaier, MD, F. Benedetti, MD, N. Mordini, MD, L. Giaccone, MD, R. Sorasio, MD, F. Fiore, MD, A. Filippi, MD, A. Palumbo, MD, M. Aglietta, MD, A. Levis, MD, R. Foà, MD, P. Di Bartolomeo, MD, E. Pogliani, MD, G. Lambertenghi-Deliliers, MD, M. Falda, MD, M. Petrini, MD, P. Corradini, MD, R. Fanin, MD, U. Ricardi, MD, R. Storb, MD, I. Baldi, B.Sc, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 3026.
https://doi.org/10.1182/blood.V110.11.3026.3026
Published: 2007
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.

Frederic Baron, R. Storb, B. Storer, D. Maloney, M. Maris, D. Niederwieser, J. Shizuru, T. Chauncey, B. Bruno, S. Forman, P. McSweeney, R. Maziarz, M. Pulsipher, E. Agura, M. Sorror, J. Wade, B. Sandmaier
Journal: Blood
Blood (2005) 106 (11): 1143.
https://doi.org/10.1182/blood.V106.11.1143.1143
Published: 2005
Journal Articles

Immunologic Recovery after Nonmyeloablative (NM) Conditioning: A Comparison between Related Versus Unrelated Donor Hematopoietic Cell Transplantation (HCT).

Frederic Baron, M. Maris, J. Storek, M. Metcalf, K. White, B. Sandmaier, D. Maloney, R. Storb, M. Boeckh
Journal: Blood
Blood (2005) 106 (11): 1402.
https://doi.org/10.1182/blood.V106.11.1402.1402
Published: 2005
Journal Articles

Donor NK Cell Engraftment and Overall and Progression-Free Survivals after Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning.

Frederic Baron, T. Gooley, M.T. Little, E. Petersdorf, M. Malkki, D. Maloney, M. Maris, P. Stroup, S. Shin, J. Baker, T. Chauncey, K. Blume, B. Sandmaier, R. Storb
Journal: Blood
Blood (2005) 106 (11): 398.
https://doi.org/10.1182/blood.V106.11.398.398
Published: 2005
Journal Articles

CMV Infection and Disease after Nonmyeloablative (NM) HCT Revisited: Incidence, Risk Factors, Ganciclovir-Related Neutropenia and Outcome.

L. Norasetthada, K. Kirby, B. Sandmaier, D. Maloney, M. Maris, C. Davis, L. Corey, R. Storb, M. Boeckh
Journal: Blood
Blood (2005) 106 (11): 3247.
https://doi.org/10.1182/blood.V106.11.3247.3247
Published: 2005
Journal Articles

HLA-Matched Unrelated Donor HCT after Nonmyeloablative Conditioning for Patients with Chronic Myeloid Leukemia.

Frederic Baron, M. Maris, B. Sandmaier, B. Storer, M. Stuart, P. McSweeney, J. Radich, M. Pulsipher, E. Agura, E. Petersdorf, S. Heimfeld, T. Chauncey, M.T. Little, D. Maloney, K. Blume, R. Storb
Journal: Blood
Blood (2004) 104 (11): 2755.
https://doi.org/10.1182/blood.V104.11.2755.2755
Published: 2004
Journal Articles

Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein

PA McSweeney, KA Rouleau, R Storb, L Bolles, PM Wallace, M Beauchamp, L Krizanac-Bengez, P Moore, G Sale, B Sandmaier, T de Revel, FR Appelbaum, RA Nash
Journal: Blood
Blood (1996) 88 (6): 1992–2003.
https://doi.org/10.1182/blood.V88.6.1992.bloodjournal8861992
Published: 1996
Journal Articles

Antibody-radionuclide conjugates as part of a myeloablative preparative regimen for marrow transplantation

FR Appelbaum, P Brown, B Sandmaier, C Badger, F Schuening, T Graham, R Storb
Journal: Blood
Blood (1989) 73 (8): 2202–2208.
https://doi.org/10.1182/blood.V73.8.2202.2202
Published: 1989